calgary : 2  alberta : 2  business : 1  wire : 1  may : 4  DD : 48  DDDD : 27  synsorb : 16  nasdaq : 3  sybb : 2  tse : 2  syb : 2  biotech : 5  inc : 6  today : 1  reported : 2  its : 2  results : 4  for : 20  the : 42  first : 8  quarter : 11  ended : 2  march : 7  total : 2  loss : 5  was : 3  D : 43  DDD : 92  or : 6  per : 3  share : 3  compared : 5  to : 17  same : 4  previous : 1  year : 1  as : 7  expected : 1  company : 3  no : 1  revenues : 1  of : 29  in : 18  products : 3  are : 1  still : 1  under : 2  development : 8  continued : 2  progress : 1  and : 29  expansion : 1  clinical : 5  trial : 3  programs : 1  company's : 6  two : 2  lead : 1  accounted : 1  majority : 1  increased : 3  expenses : 5  with : 7  operating : 4  decreased : 1  during : 3  period : 9  this : 2  decrease : 2  can : 1  be : 2  attributable : 1  costs : 2  associated : 2  listing : 1  on : 8  national : 1  market : 2  reduced : 1  salaries : 1  related : 1  over : 1  primarily : 1  due : 1  interest : 3  payments : 1  long : 5  term : 9  debt : 5  which : 4  put : 1  place : 1  late : 2  at : 5  cash : 11  investment : 1  balance : 2  has : 3  been : 1  very : 1  productive : 1  we : 2  have : 1  enrollment : 1  our : 4  phase : 2  iii : 1  pk : 2  r : 4  ii : 1  cd : 2  said : 1  david : 1  cox : 1  ph : 1  d : 1  president : 1  chief : 1  executive : 1  officer : 1  also : 1  announced : 1  a : 4  research : 4  agreement : 1  ocean : 1  pharmaceuticals : 1  commenced : 1  operations : 1  manufacturing : 1  facility : 1  finalized : 1  acquisition : 2  oncolytics : 1  filed : 2  preliminary : 1  prospectus : 1  complete : 1  public : 2  offering : 2  closed : 1  raised : 1  net : 4  proceeds : 3  million : 1  re : 1  established : 1  balances : 4  levels : 1  required : 1  meet : 1  future : 1  milestones : 1  is : 1  dedicated : 1  accelerated : 1  drug : 1  from : 4  promising : 1  compounds : 2  emerging : 1  basic : 1  through : 2  ultimately : 1  providing : 1  channels : 1  new : 1  discoveries : 1  headquartered : 1  currently : 1  stage : 1  prevention : 1  hus : 1  treatment : 1  verotoxigenic : 1  e : 1  coli : 1  vtec : 1  infections : 1  including : 2  oDDD : 1  hD : 1  designed : 1  treat : 1  recurrent : 1  antibiotic : 1  diarrhea : 1  cdad : 1  additional : 1  pre : 1  potential : 1  cancer : 1  treatments : 1  novel : 1  antibiotics : 1  inflammation : 1  anti : 1  virals : 1  targeted : 1  program : 1  release : 1  contains : 1  certain : 1  forward : 2  looking : 2  statements : 4  involve : 1  known : 1  unknown : 1  risks : 1  delays : 1  uncertainties : 1  other : 3  factors : 3  not : 1  control : 1  cause : 1  actual : 1  performance : 2  achievements : 1  materially : 1  different : 1  expectations : 1  implied : 1  by : 2  these : 2  include : 1  current : 6  pending : 1  trials : 1  actions : 1  fda : 1  hpb : 1  those : 1  detailed : 1  registration : 1  statement : 1  form : 1  f : 1  securities : 1  exchange : 1  commission : 1  consolidated : 3  interim : 3  sheets : 1  DDD's : 3  assets : 4  deposits : 4  note : 3  accounts : 2  receivable : 1  prepaid : 1  advance : 1  director : 1  capital : 4  liabilities : 3  shareholders' : 2  equity : 2  payable : 1  accruals : 1  portion : 2  non : 4  heritage : 1  foundation : 1  less : 1  issued : 3  common : 4  shares : 4  deficit : 4  issuance : 1  Dm : 2  three : 2  months : 2  ending : 2  revenue : 2  income : 1  amortization : 2  beginning : 2  end : 2  flows : 1  activities : 5  add : 1  item : 1  change : 2  working : 2  relating : 2  investing : 2  purchase : 1  financing : 1  exercise : 1  options : 1  warrants : 1  private : 1  placement : 1  repayment : 1  increase : 1  